Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

443 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials.
Sherry AD, Lin TA, McCaw ZR, Beck EJ, Kouzy R, Abi Jaoude J, Passy AH, Miller AM, Kupferman GS, Fuller CD, Thomas CR Jr, Koay EJ, Tang C, Msaouel P, Ludmir EB. Sherry AD, et al. Int J Radiat Oncol Biol Phys. 2024 Aug 2:S0360-3016(24)02963-8. doi: 10.1016/j.ijrobp.2024.05.033. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39352322
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy.
Sherry AD, Msaouel P, McCaw ZR, Abi Jaoude J, Hsu EJ, Kouzy R, Patel R, Yang Y, Lin TA, Taniguchi CM, Rödel C, Fokas E, Tang C, Fuller CD, Minsky B, Meirson T, Sun R, Ludmir EB. Sherry AD, et al. Eur J Cancer. 2023 Nov;194:113357. doi: 10.1016/j.ejca.2023.113357. Epub 2023 Sep 22. Eur J Cancer. 2023. PMID: 37827064 Free article.
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials.
Hsu EJ, Lin TA, Dabush DR, McCaw Z, Koong A, Lin C, Abi Jaoude J, Patel R, Kouzy R, El Alam MB, Noticewala S, Yang Y, Sherry AD, Fuller CD, Thomas CR Jr, Tang C, Msaouel P, Das P, Huang B, Tian L, Sun R, Lee JJ, Meirson T, Ludmir EB. Hsu EJ, et al. Among authors: sherry ad. J Natl Cancer Inst. 2024 Jun 7;116(6):990-994. doi: 10.1093/jnci/djae028. J Natl Cancer Inst. 2024. PMID: 38331394
Interpretation of long-term survival data from MONARCH 3. Letter to the Editor regarding "Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3" by M. P. Goetz et al.
Sherry AD, Lin TA, McCaw ZR, Ludmir EB. Sherry AD, et al. Ann Oncol. 2024 Aug;35(8):747-748. doi: 10.1016/j.annonc.2024.05.543. Epub 2024 Jun 3. Ann Oncol. 2024. PMID: 38838846 No abstract available.
Metastases-Targeting Radiotherapy and ADT-Reply.
Sherry AD, Corn PG, Tang C. Sherry AD, et al. JAMA Oncol. 2023 Nov 1;9(11):1587-1588. doi: 10.1001/jamaoncol.2023.3631. JAMA Oncol. 2023. PMID: 37707804 No abstract available.
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial.
Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Cohen L, Aparicio A, Zurita AJ, Reuben A, Marmonti E, Chun SG, Reddy JP, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Pilie P, Kovitz C, Du W, Simiele SJ, Kumar R, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn PG. Tang C, et al. Among authors: sherry ad. JAMA Oncol. 2023 Jun 1;9(6):825-834. doi: 10.1001/jamaoncol.2023.0161. JAMA Oncol. 2023. PMID: 37022702 Free PMC article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 38579843
443 results